Adult-onset Still's disease complicated with macrophage activation syndrome: A case report
<p>Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Adult-onset Still'...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Journal of Vaccines and Immunology - Peertechz Publications,
2022-07-23.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | peertech__10_17352_jvi_000051 | ||
042 | |a dc | ||
100 | 1 | 0 | |a MNSK Perera |e author |
700 | 1 | 0 | |a A Gunapala |e author |
245 | 0 | 0 | |a Adult-onset Still's disease complicated with macrophage activation syndrome: A case report |
260 | |b Journal of Vaccines and Immunology - Peertechz Publications, |c 2022-07-23. | ||
520 | |a <p>Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Adult-onset Still's disease is a rare systemic disease while macrophage activation syndrome is a fulminant complication of Still's disease. As mortality is high in macrophage activation syndrome, prompt diagnosis is crucial to commence definitive management. Macrophage activation syndrome is a complication of adult-onset Still's disease. When first-line immunosuppressives fail, second-line medications including biologic therapy can be considered with good results. </p> | ||
540 | |a Copyright © MNSK Perera et al. | ||
546 | |a en | ||
655 | 7 | |a Case Report |2 local | |
856 | 4 | 1 | |u https://doi.org/10.17352/jvi.000051 |z Connect to this object online. |